)
Visual22 Oct 2025
Epiroc's cash spent on M&A
Active Biotech (ACTI) investor relations material
Active Biotech Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary21 Aug, 2025
Executive summary
Achieved key clinical milestones in hematological oncology and inflammatory eye diseases, advancing prioritized projects and reporting positive clinical data for tasquinimod and laquinimod.
Presented final results from the tasquinimod multiple myeloma study at ASCO 2025 and positive top-line results from the LION laquinimod eye study.
Initiated two proof-of-concept clinical studies for tasquinimod in myelofibrosis in the US and Europe.
Focus remains on progressing tasquinimod in myelofibrosis and securing a partnership for laquinimod.
Financial highlights
No sales recorded in Q2 2025; operating loss was SEK 11.3M compared to SEK 10.7M in Q2 2024.
Loss after tax for Q2 2025 was SEK 11.2M (Q2 2024: SEK 10.6M); EPS was SEK -0.01 (Q2 2024: SEK -0.03).
Cash and cash equivalents at period end were SEK 16.8M, down from SEK 27.4M at year-end 2024.
Research and development expenses increased 11% year-over-year to SEK 15.8M for H1 2025.
Equity/assets ratio for the Group was 46.3% at June 30, 2025 (75.8% at year-end 2024).
Outlook and guidance
Ongoing focus on advancing tasquinimod in myelofibrosis and establishing commercial partnerships for laquinimod.
Available liquidity expected to fund operations through 2025; additional financing will be required for continued progress.
Board is actively exploring financing options, including partnerships and share issuances.
How will tasquinimod study amendments affect timelines?
What is the strategy for laquinimod commercial partnership?
Why are naptumomab studies in India and Israel?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Active Biotech earnings date
Q3 20256 Nov, 2025
Next Active Biotech earnings date
Q3 20256 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Active Biotech AB is a Swedish biotechnology company focused on developing treatments for cancer and inflammatory diseases. Its key projects include Tasquinimod, an immunomodulatory molecule in clinical trials for multiple myeloma and myelofibrosis, and Laquinimod, aimed at treating inflammatory eye disorders like uveitis. Additionally, Naptumomab, an antibody-based immunotherapy, is being tested in combination with other treatments for solid tumors, including non-small cell lung cancer. The company is headquartered in Lund, Sweden, and is listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage